MB

Merav Bassan

PN Prilenia Neurotherapeutics: 4 patents #3 of 28Top 15%
University Of Texas System: 2 patents #1,567 of 6,559Top 25%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
RU Ramot At Tel-Aviv University: 1 patents #468 of 1,095Top 45%
📍 Netanya, IL: #125 of 1,776 inventorsTop 8%
Overall (All Time): #485,317 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12390456 Pridopidine for treating Huntington's disease Esther Lukasiewicz Hagai, Eli Eyal, Anna Kristina Sveinsdotter Teige Wickenberg 2025-08-19
11471449 Use of pridopidine to improve cognitive function and for treating Alzheimer's disease Michal GEVA, Ilya Bezprozvanny, Michael Hayden 2022-10-18
11090297 Pridopidine for treating huntington's disease Esther Lukasiewicz Hagai, Eli Eyal, Anna Kristina Sveinsdotter Teige Wickenberg 2021-08-17
10603311 Use of pridopidine to improve cognitive function and for treating Alzheimer's disease Michal GEVA, Ilya Bezprozvanny, Michael Hayden 2020-03-31
10322119 Use of pridopidine for treating Huntington's disease Esther Lukasiweicz Hagai, Eli Eyal, Anna Kristina Sveinsdotter Teige Wickenberg 2019-06-18
7863247 Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides Douglas E. Brenneman, Catherine Y. Spong, Illana Gozes, Rachel Zamostiano 2011-01-04
7264947 Activity dependent neurotrophic factor III (ADNF III) Illana Gozes, Douglas E. Brenneman, Rachel Zamostiano 2007-09-04
6933277 Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides Douglas E. Brenneman, Catherine Y. Spong, Illana Gozes, Rachel Zamostiano 2005-08-23
6649411 Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides Illana Gozes, Douglas E. Brenneman, Rachel Zamostiano, Edgar Gelber, Albert Pinhasov 2003-11-18
6613740 Activity dependent neurotrophic factor III (ADNF III) Illana Gozes, Douglas E. Brenneman, Rachel Zamostiano 2003-09-02